Back to search

Article

Genetic association of primary non-response to Anti-TNFα therapy in patients with Inflammatory Bowel Disease

2020-06-24

Abstract excerpt

<h4>Background & Aims</h4> Primary non-response (PNR) to anti-tumor necrosis factor-α (TNFα) biologics is a serious concern in patients with inflammatory bowel disease (IBD). We aimed to identify the genetic variants associated with PNR. <h4>Methods</h4> Patients were recruited from outpatient GI clinics and PNR was determined using both clinical and endoscopic findings. A case-control genome-wide association stud...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c877e6b8-de67-56e8-8b3c-75bf1c284835
DOI
10.1101/2020.06.23.20138495
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genetic association of primary non-response to Anti-TNFα therapy in patients with Inflammatory Bowel DiseaseDOI 10.1101/2020.06.23.20138495
Genetic Markers Predict Primary Non-Response and Durable Response To Anti-TNF Biologic Therapies in Crohn's Disease.Semantic proximity
Therapeutic Strategies for Anti-TNF Non-Responsive IBD PatientsSemantic proximity
Associations between functional polymorphisms in the NFκB signaling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease.Semantic proximity
The Clinical Response of Upadacitinib and Risankizumab is Associated with Reduced Inflammatory Bowel Disease Anti-TNFα Inadequate Response MechanismsSemantic proximity
Colonic Phenotypes Are Associated with Poorer Response to Anti-TNF Therapies in Patients with IBD.Semantic proximity
Systematic review: genetic biomarkers associated with anti-TNF treatment response in inflammatory bowel diseases.Semantic proximity
Genetically determined high activity of IL-12 and IL-18 in ulcerative colitis and TLR5 in Crohns disease were associated with non-response to anti-TNF therapy.Semantic proximity
Genetic polymorphisms in tumour necrosis factor receptors (TNFRSF1A/1B) illustrate differential treatment response to TNFα inhibitors in patients with Crohn’s diseaseSemantic proximity
Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients.Semantic proximity
Identification of a novel transcriptome signature for predicting the response to anti-TNF-α treatment in rheumatoid arthritis patientsSemantic proximity
Baseline expression of immune gene modules in blood is associated with primary response to anti-TNF therapy in Crohn’s disease patientsSemantic proximity
Multiome-seq links inflammatory bowel disease polygenic risk to TNF inhibitor responseSemantic proximity
Select a neighboring publication to make it the new centre.